Who Paid My Doc
Christopher Bird
Aerospace Medicine Robins Afb, GA Medical Doctor
NPI 1568412997 CMS profile 1261299
655 South 7Th Street Bldg 700/700-A, 78 Mdg/Sghc, Robins Afb, GA 31098
General payments
$23
Research payments
$0
Ownership & investment interest
$0
Through program year 2023, Christopher Bird of Robins Afb, GA is reported in the CMS Open Payments database as having received $23 across 1 general payment and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 15th percentile of Aerospace Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2023 | General | $23 | 1 |
Beside peers
- Christopher Bird
- Aerospace Medicine median
- Middle half of Aerospace Medicine
- National median
In program year 2025, general payments to Christopher Bird were reported at $0. Among 42 Aerospace Medicine profiles paid that year, the median was $90 and the middle half received between $33 and $238.
Show as a table
| Year | Christopher Bird | Aerospace Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $54 | $26–$230 | $163 |
| 2020 | $0 | $62 | $20–$173 | $114 |
| 2021 | $0 | $118 | $44–$253 | $132 |
| 2022 | $0 | $50 | $16–$110 | $149 |
| 2023 | $23 | $108 | $25–$207 | $160 |
| 2024 | $0 | $52 | $27–$373 | $164 |
| 2025 | $0 | $90 | $33–$238 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 1 drugPart D claims
22
Drug cost
$183
Branded share of claims
0%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Doxycycline Hyclate | Generic | 22 | $183 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero.
Billing to Medicare
Part B · data year 2024 · 14 billing codesPaid by Medicare
$50,918
Medicare patients
171
Services billed
765
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 68% | |
| Chronic kidney disease | 50% | |
| Diabetes | 47% | |
| Depression | 47% | |
| Ischemic heart disease | 46% | |
| Heart failure | 41% | |
| Atrial fibrillation | 33% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
1 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Aerospace Medicine in Georgia
Related records
Aerospace Medicine in Georgia
Practitioners in the same specialty and state, ranked by reported value.
All Aerospace Medicine
Everyone recorded under this specialty, nationwide.
Doctors in Georgia
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.